You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Colorcon
Baxter
Johnson and Johnson
McKinsey

Last Updated: April 1, 2020

DrugPatentWatch Database Preview

PLIAGLIS Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Pliaglis patents expire, and when can generic versions of Pliaglis launch?

Pliaglis is a drug marketed by Taro Pharms and is included in one NDA. There are two patents protecting this drug.

This drug has twenty-three patent family members in twelve countries.

The generic ingredient in PLIAGLIS is lidocaine; tetracaine. There are twenty-nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the lidocaine; tetracaine profile page.

US ANDA Litigation and Generic Entry Outlook for Pliaglis

Indicators of Generic Entry

< Available with Subscription >

  Start Trial

Summary for PLIAGLIS
Drug patent expirations by year for PLIAGLIS
Drug Prices for PLIAGLIS

See drug prices for PLIAGLIS

Recent Clinical Trials for PLIAGLIS

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
American Association of EndodontistsPhase 4
University of MichiganPhase 4
Galderma Laboratories, L.P.Phase 4

See all PLIAGLIS clinical trials

Pharmacology for PLIAGLIS

US Patents and Regulatory Information for PLIAGLIS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro Pharms PLIAGLIS lidocaine; tetracaine CREAM;TOPICAL 021717-001 Jun 29, 2006 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Taro Pharms PLIAGLIS lidocaine; tetracaine CREAM;TOPICAL 021717-001 Jun 29, 2006 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Colorcon
Baxter
Johnson and Johnson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.